Actualités Leica Biosystems

The NSH Annual Symposium/Convention forms the largest educational event of its kind working to advance and promote the histology profession. NSH is the premier source of learning, knowledge and future-oriented research for histology professionals. Attendance provides resources, education, ideas and…

Leica Biosystems is proudly unveiling our Next Generation Scanner at Booth #405 on September 22nd, at 11:45 a.m.

VISTA, CA – Aug 9, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading with priority…

Come visit Leica Biosystems at the 5th Digital Pathology & AI Congress: USA booth #13 and learn more about our Imaging Solutions portfolio in hardware and software.

VISTA, CA –May 29, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S. A multi-center study supporting this…

Come visit Leica Biosystems at our Patho Informatics booth #Gold 1 and learn more about our Aperio imaging solutions portfolio.

VISTA, CA – January 7th, 2019 – Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590). This will enable high volume, extremely fast line…

NEWCASTLE, ENGLAND, UK NOVEMBER 2018 – Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform. The new PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (…

Register Now for On Demand Abstract: Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of histopathological features of disease. However, the multiplexing…

Melbourne, Australia and Cambridge, Massachusetts – September 14, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours. Building on its legacy of partnering with emerging technology leaders, Leica…